# NEODIAGNOSTIX INC — Form D

NEODIAGNOSTIX INC of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2009-10-27. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-10-27
- Form: D
- Accession: 0001396879-09-000004
- Industry: Biotechnology
- Exemptions: 06, 46
- Total offering: $1.5M
- Amount sold: $1.5M
- Minimum investment: $10K
- Investors: 13
- Date of first sale: 2009-03-05
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-102270

## Issuer

- Name: NEODIAGNOSTIX INC
- CIK: 0001396879
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 9700 GREAT SENECA HGWY, ROCKVILLE, MD, 20850
- Phone: 240-821-1405

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth Carter | Director | SAN FRANCISCO, CA |
| William Gust | Director | Baltimore, MD |
| Bradley Lorimier | Director | Vero Beach, FL |
| Gregory Endress | Executive Officer | Rockville, MD |
| Richard Pinnola | Executive Officer | Belchertown, MA |

## More

- [CIK 1396879 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1396879&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001396879-09-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.